Tumor weight ↓; liver and spleen indexes ↓; IL-2 and IL-10 levels ↓; inhibition rates were 66.39, 63.11, and 47.33%, respectively; WBC, HGB, and PLT numbers ↑; TLR4, MyD88, and NF-κB expressions ↓. This evidence concerns the gene MYD88 and neoplasm.